| 1JMO | L:1T-14M | CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX |
| 1JOU | E:1R-15; E:1R-15; E:1R-15 | CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH AN UNOCCUPIED ACTIVE SITE |
| 1K21 | L:1B-14K | HUMAN THROMBIN-INHIBITOR COMPLEX |
| 1K22 | L:1C-14L | HUMAN THROMBIN-INHIBITOR COMPLEX |
| 1KTS | A:1C-14J | THROMBIN INHIBITOR COMPLEX |
| 1KTT | A:1C-14J | THROMBIN INHIBITOR COMPLEX |
| 1LHC | L:1B-14J | HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROARG-OH |
| 1LHD | L:1B-14J | HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROLYS-OH |
| 1LHE | L:1B-14J | HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH |
| 1LHF | L:1B-14J | HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-HOMOLYS-OH |
| 1LHG | L:1B-14J | HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROORNITHINE-OH |
| 1MH0 | B:1B-14K; B:1B-14K | CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN |
| 1MU6 | A:1A-14K | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622 |
| 1MU8 | A:1A-14K | THROMBIN-HIRUGEN_L-378,650 |
| 1MUE | A:1A-14K | THROMBIN-HIRUGEN-L405,426 |
| 1NM6 | A:1A-14K | THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT 1.8A |
| 1NO9 | L:1H-15 | DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATING NOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X-RAY CRYSTALLOGRAPHIC STUDIES. |
| 1NRN | L:1A-15 | CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES |
| 1NRO | L:1A-15 | CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES |
| 1NRP | L:1A-15 | CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES |
| 1NRQ | L:1A-14H | CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES |
| 1NRR | L:1B-14J | CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES |
| 1NRS | L:1B-14K | CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES |
| 1NT1 | A:1-14K | THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR |
| 1NU7 | E:1C-14J; E:1C-14J | STAPHYLOCOAGULASE-THROMBIN COMPLEX |
| 1NU9 | D:1D-15; D:1D-15 | STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX |
| 1NY2 | 1:1H-15 | HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN |
| 1O0D | L:1F-15 | HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO-ARG-TYPE INHIBITOR AND A C-TERMINAL HIRUDIN DERIVED EXO-SITE INHIBITOR |
| 1O2G | L:1H-15 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
| 1O5G | L:1H-14K | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) |
| 1OOK | A:1H-15 | CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN |
| 1OYT | L:1B-14K | COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR |
| 1P8V | B:1-29 | CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND ALPHA-THROMBIN AT 2.6A |
| 1PPB | L:1H-15 | THE REFINED 1.9 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN: INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT |
| 1QBV | L:1A-14J | CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE-MIMETIC INHIBITOR |
| 1QHR | A:1H-15 | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS |
| 1QJ1 | A:1H-15 | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS |
| 1QJ6 | A:1H-15 | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS |
| 1QUR | L:1B-14K | HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE-BASED SYNTHETIC INHIBITOR |
| 1RD3 | C:1E-14L; C:1E-14L | 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K |
| 1RIW | A:7-33 | THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOR OSCILLARIN |
| 1SFQ | D:1B-14L; D:1B-14L | FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK |
| 1SG8 | D:1B-14K; D:1B-14K | CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN |
| 1SHH | D:1B-14M; D:1B-14M | SLOW FORM OF THROMBIN BOUND WITH PPACK |
| 1SL3 | A:1-14L | CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1 HETEROCYCLE-ARYL BASED INHIBITOR |
| 1SR5 | B:1G-14K | ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE |
| 1T4V | L:7-32 | CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN |
| 1TA2 | A:1A-14K | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1 |
| 1TA6 | A:1A-14K | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B |
| 1TBZ | L:1-14K | HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L-PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN |
| 1THP | A:1B-14K | STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE |
| 1THR | L:1B-14K | STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR |
| 1THS | L:1E-15 | STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR |
| 1TMT | L:1B-14K | CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS |
| 1TMU | L:1C-14K | CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS |
| 1TOM | L:1B-14J | ALPHA-THROMBIN COMPLEXED WITH HIRUGEN |
| 1TQ0 | C:1B-14L; C:1B-14L | CRYSTAL STRUCTURE OF THE POTENT ANTICOAGULANT THROMBIN MUTANT W215A/E217A IN FREE FORM |
| 1TQ7 | A:1P-15 | CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANT W215A/E217A BOUND TO PPACK |
| 1TWX | A:1B-14L | CRYSTAL STRUCTURE OF THE THROMBIN MUTANT D221A/D222K |
| 1UMA | L:1H-15 | ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N-DIMETHYLCARBAMOYL)-ALPHA-AZALYSINE |
| 1UVS | L:1B-14K | BOVINE THROMBIN--BM51.1011 COMPLEX |
| 1VR1 | L:1B-14K | SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR-1 |
| 1VZQ | L:1B-14K | COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 |
| 1W7G | L:1A-15 | ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54-65) AND L-ARGININE TEMPLATE INHIBITOR CS107 |
| 1WAY | A:1D-14K | ACTIVE SITE THROMBIN INHIBITORS |
| 1WBG | A:1D-15 | ACTIVE SITE THROMBIN INHIBITORS |
| 1XM1 | A:1B-14K | NONBASIC THROMBIN INHIBITOR COMPLEX |
| 1XMN | G:1D-14M; G:1D-14M; G:1D-14M; G:1D-14M | CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN |
| 1YPE | L:1B-14K | THROMBIN INHIBITOR COMPLEX |
| 1YPG | L:1B-14K | THROMBIN INHIBITOR COMPLEX |
| 1YPJ | L:1B-14K | THROMBIN INHIBITOR COMPLEX |
| 1YPK | L:1B-14K | THROMBIN INHIBITOR COMPLEX |
| 1YPL | L:1B-14K | X-RAY CRYSTAL STRUCTURE OF THROMBIN INHIBITED BY SYNTHETIC CYANOPEPTIDE ANALOGUE RA-1008 |
| 1YPM | L:1B-14K | X-RAY CRYSTAL STRUCTURE OF THROMBIN INHIBITED BY SYNTHETIC CYANOPEPTIDE ANALOGUE RA-1014 |
| 1Z71 | A:1-14K | THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE |
| 1Z8I | A:1L-14L | CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193A BOUND TO PPACK |
| 1Z8J | A:1N-14L | CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193P BOUND TO PPACK |
| 1ZGI | A:1A-14K | THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 21 |
| 1ZGV | A:1A-14K | THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 2 |
| 1ZRB | A:1A-14K | THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B |
| 2JH0 | C:1B-15 | HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX |
| 2JH5 | C:1B-15 | HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX |
| 2JH6 | C:1B-15 | HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX |
| 2OD3 | A:1B-14L | HUMAN THROMBIN CHIMERA WITH HUMAN RESIDUES 184A, 186, 186A, 186B, 186C AND 222 REPLACED BY MURINE THROMBIN EQUIVALENTS. |
| 2PGB | A:1H-14M | INHIBITOR-FREE HUMAN THROMBIN MUTANT C191A-C220A |
| 2PGQ | A:1Q-14L | HUMAN THROMBIN MUTANT C191A-C220A IN COMPLEX WITH THE INHIBITOR PPACK |
| 2PKS | A:7-33 | THROMBIN IN COMPLEX WITH INHIBITOR |
| 2PW8 | L:1B-14K | CRYSTAL STRUCTURE OF SULFO-HIRUDIN COMPLEXED TO THROMBIN |
| 2R2M | A:7-32 | 2-(2-CHLORO-6-FLUOROPHENYL)ACETAMIDES AS POTENT THROMBIN INHIBITORS |
| 2THF | A:1A-14K | STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE |
| 2UUF | A:1B-14L | THROMBIN-HIRUGEN BINARY COMPLEX AT 1.26A RESOLUTION |
| 2UUK | A:1B-14L | THROMBIN-HIRUGEN-GW420128 TERNARY COMPLEX AT 1.39A RESOLUTION |
| 2V3H | L:1B-14L | THROMBIN WITH 3-CYCLE NO F |
| 2V3O | L:1B-14L | THROMBIN WITH 3-CYCLE WITH F |
| 2ZC9 | L:1C-14K | THROMBIN IN COMPLEX WITH INHIBITOR |
| 2ZDV | L:1C-14K | EXPLORING THROMBIN S1 POCKET |
| 2ZF0 | L:1C-14K | EXPLORING THROMBIN S1 POCKET |
| 2ZFF | L:1C-14K | EXPLORING THROMBIN S1-POCKET |
| 2ZFP | L:1C-14K | THROMBIN INIBITION |
| 2ZFQ | L:1B-14K | EXPLORING THROMBIN S3 POCKET |
| 2ZFR | L:1C-14K | EXPLORING THROMBIN S3 POCKET |
| 2ZG0 | L:1B-14K | EXPLORING THROMBIN S3 POCKET |
| 2ZGB | L:1B-14K | THROMBIN INHIBITION |
| 2ZGX | L:1B-14K | THROMBIN INHIBITION |
| 2ZHE | L:1B-14K | EXPLORING THROMBIN S3 POCKET |
| 2ZHF | L:1B-14K | EXPLORING THROMBIN S3 POCKET |
| 2ZHQ | L:1C-14K | THROMBIN INHIBITION |
| 2ZHW | L:1B-14K | EXPLORING THROMBIN S3 POCKET |
| 2ZI2 | L:1B-14K | THROMBIN INHIBITION |
| 2ZIQ | L:1C-14K | THROMBIN INHIBITION |
| 2ZNK | L:1C-14K | THROMBIN INHIBITION |
| 2ZO3 | L:1B-14K | BISPHENYLIC THROMBIN INHIBITORS |
| 3JZ1 | A:1C-14M | CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT N143P IN E:NA+ FORM |
| 3JZ2 | A:1D-14K | CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT N143P IN E* FORM |
| 3K65 | B:279-320 | CRYSTAL STRUCTURE OF PRETHOMBIN-2/FRAGMENT-2 COMPLEX |
| 3LU9 | D:1R-14M; D:1R-14M | CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT S195A IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF HUMAN PAR1 |
| 3NXP | A:274-320 | CRYSTAL STRUCTURE OF HUMAN PRETHROMBIN-1 |
| 3P6Z | G:334-362; G:334-362 | STRUCTURAL BASIS OF THROMBIN MEDIATED FACTOR V ACTIVATION: ESSENTIAL ROLE OF THE HIRUDIN-LIKE SEQUENCE GLU666-GLU672 FOR PROCESSING AT THE HEAVY CHAIN-B DOMAIN JUNCTION |
| 3PMH | A:1H-15 | MECHANISM OF SULFOTYROSINE-MEDIATED GLYCOPROTEIN IB INTERACTION WITH TWO DISTINCT ALPHA-THROMBIN SITES |
| 3QDZ | C:1C-14L; C:1C-14L | CRYSTAL STRUCTURE OF THE HUMAN THROMBIN MUTANT D102N IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF HUMAN PAR4. |
| 3QGN | A:1C-14L | THE ALLOSTERIC E*-E EQUILIBRIUM IS A KEY PROPERTY OF THE TRYPSIN FOLD |
| 3R3G | A:1C-14L | STRUCTURE OF HUMAN THROMBIN WITH RESIDUES 145-150 OF MURINE THROMBIN. |
| 3S7H | A:1B-14K | STRUCTURE OF THROMBIN MUTANT Y225P IN THE E* FORM |
| 3S7K | C:1E-15; C:1E-15 | STRUCTURE OF THROMBIN MUTANT Y225P IN THE E FORM |
)
)